Treating Multiple Sclerosis With Sirolimus, an Immune System Suppressor

Clinical trial NCT00095329 · TERMINATED

Trial details

NCT number: NCT00095329
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Multiple Sclerosis (MS) - Relapsing-remitting

Start date: 2003-05-01
Primary completion: 2005-03-01
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.